Total Visits

Views
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 35

Total Visits Per Month

September 2018October 2018November 2018December 2018January 2019February 2019March 2019
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 2 2 2 4 5 2 0

File Visits

Views
12885_2018_Article_4442.pdf 10

Top country views

Views
United States 10
Egypt 6
United Kingdom 3
Pakistan 2
Canada 1
Germany 1
Russia 1

Top cities views

Views
Woodbridge 4
Ashburn 3
Islamabad 2
Mountain View 2
Houston 1